March 2, 2026

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 54% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its promising focus on treating metabolic dysfunction-associated steatohepatitis (MASH)...

Royalty Pharma plc (RPRX): Investor Outlook with 11.57% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands at a pivotal position in the biotechnology sector, offering a unique investment opportunity through its innovative business model. As a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Solid Growth Prospects with a 2.91% Potential Upside

The Ensign Group, Inc. (ENSG) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry, where it has carved out a..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unveiling a 17% Upside Potential for Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is capturing attention in the biotechnology sector with a potential upside of 17.16%, as analysts project a promising future for this..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Fresenius Medical Care AG (FMS): Investor Outlook Reveals 17.34% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a global leader in dialysis services and products, stands as a noteworthy player in the healthcare sector, particularly within the..

HealthEquity, Inc. (HQY) Stock Analysis: Unveiling a 49.61% Upside Potential

Investors eyeing the healthcare sector may find HealthEquity, Inc. (NASDAQ: HQY) an intriguing proposition, given its robust service offerings and promising market position. Headquartered in Draper,..

Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside with Strong Buy Ratings

For investors seeking exposure to the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents an intriguing opportunity. With a market cap of $10.26 billion, this Netherlands-based company..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.78% Potential Upside in Healthcare

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is capturing investor attention with a robust market capitalization of $101.65 billion. The company, renowned..

Pfizer, Inc. (PFE) Stock Analysis: Navigating the Healthcare Giant’s Growth Potential Amidst a 6.22% Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a stalwart in the healthcare sector, renowned for its robust portfolio of biopharmaceutical products that cater to a wide range..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking Its 20.36% Potential Upside Amidst Mixed Financials

Avantor, Inc. (NYSE: AVTR) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, with its vast array of mission-critical products and..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring the 32% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $4.58..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector, is attracting investor attention with its strong potential upside of 16.36%. As a company operating..

Encompass Health Corporation (EHC) Stock Analysis: A 32% Upside in the Healthcare Sector

Encompass Health Corporation (NYSE: EHC) is a dominant player in the healthcare sector, specifically within the medical care facilities industry. Known for its comprehensive post-acute healthcare..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Healthcare Giant with a 5.45% Upside Potential

For investors eyeing opportunities in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing option. With a storied history dating back to 1781,..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.71% Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to solidify its position as a key player in the medical instruments and..

Amgen Inc. (AMGN) Stock Report: Evaluating the 106% Return on Equity and Market Prospects

For individual investors keeping a keen eye on the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling case with its impressive return on equity (ROE)..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth with a 2.28% Upside Potential

Molina Healthcare Inc (NYSE: MOH) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. As of its latest trading session, the..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 33.92% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out in the healthcare sector as a dynamic force within the specialty and generic drug manufacturing industry. Headquartered in San..

ICON plc (ICLR) Stock Analysis: Unpacking the 37% Upside Potential

Investors eyeing the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a leading player in the diagnostics and research industry...

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds